On Wednesday, Shares of Anadarko Petroleum Corporation (NYSE:APC), lost -1.08% to $77.22.
Anadarko Petroleum Corporation, declared that the Saddlehorn Pipeline system will extend to Carr, CO. The 50-mile pipeline extension from Platteville to Carr, which is anticipated to be constructed with 16-inch diameter pipe, will provide a connection to existing crude oil assets in that region. This extension has been designed to provide shippers with flexible options and streamlined access into the Saddlehorn Pipeline system.
Saddlehorn is a limited liability company owned by Magellan Midstream Partners, L.P. (MMP), Plains All American Pipeline, L.P. (PAA) and Anadarko Petroleum Corporation (APC). Saddlehorn will construct, own and operate the about 600-mile pipeline (counting the Carr extension) that will transport various grades of crude oil from the DJ Basin, and potentially the broader Rocky Mountain and Bakken area resource plays, to storage facilities in Cushing, OK owned by Magellan and Plains. The 20-inch pipeline from Platteville to Cushing ultimately has the capacity to transport up to 400,000 barrels per day (bpd), with the initial capacity predictable to be closer to 200,000 bpd.
The Carr extension project is presently estimated to cost between $80 million and $100 million. Magellan will serve as construction manager and operator of the Saddlehorn Pipeline system. Subject to receipt of necessary permits and regulatory approvals, the Platteville to Cushing pipeline is predictable to be operational during mid-2016 and the extension to Carr is anticipated to be in service by the end of 2016.
Anadarko Petroleum Corporation engages in the exploration, development, production, and marketing of oil and gas properties. It operates through three segments: Oil and Gas Exploration and Production; Midstream; and Marketing.
Shares of Patterson-UTI Energy, Inc. (NASDAQ:PTEN), declined -5.71% to $17.74, during its last trading session.
Patterson-UTI Energy, will hold its conference call to talk about results for the second quarter ended June 30, 2015 on Thursday, July 23, 2015 at 9:00 a.m. Central Time.
Patterson-UTI Energy, Inc., through its auxiliaries, provides onshore contract drilling services to major and independent oil and natural gas operators in the United States and Canada.
Finally, Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), ended its last trade with 2.91% gain, and closed at $60.84.
Teva Pharmaceutical Industries Ltd, declared the launch of generic Aggrenox capsules in the United States. Aspirin and extended-release dipyridamole capsules are used to lower the risk of stroke in people who have had a mini-stroke (transient ischemic attack or TIA) or stroke due to a blood clot.
“The National Institutes of Health estimates 185,000 Americans are at risk of another stroke within 5 years of a previous stroke. Teva recognizes the devastating impact of a stroke and is happy to launch generic aspirin and extended-release dipyridamole capsules as a treatment option for at-risk stroke patients,” said Brendan O’Grady, President and CEO, North America Generic Medicines for Teva. “Being able to make affordable, high-quality generic medicines accessible to millions of patients every day is our commitment at Teva.”
A stroke is caused when there is an interruption to the flow of oxygen rich blood to the brain. Without oxygen, brain cells can become damaged and die. Sudden bleeding in the brain can also cause a stroke if it damages brain cells. A stroke can result in brain damage, long-term disability, or even death.
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic, specialty, and other pharmaceutical products worldwide. The company operates in two segments, Generic Medicines and Specialty Medicines.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
